October 2023—PixCell Medical announced that the FDA has granted 510(k) clearance for direct capillary sampling with the HemoScreen 5-part differential CBC analyzer. The clearance enables collection of a sample directly from a patient’s finger without an intermediate tube. HemoScreen is also FDA cleared for point-of-care use with venous and capillary blood.
Read More »Home >> Tag Archives: PixCell Medical
FDA clears PixCell HemoScreen for direct capillary sampling
Aug. 24, 2023—PixCell Medical announced that the FDA has granted 510(k) clearance for direct capillary sampling with the HemoScreen 5-part differential CBC analyzer.
Read More »PixCell Medical opens U.S. subsidiary in Denver
December 2021—PixCell Medical (Yokne’am Illit, Israel) announced it has opened a U.S. subsidiary in the Denver metropolitan area. The new office aims to increase logistical and commercial support for the company’s U.S. clients and will handle order fulfilment across the country as well as provide additional clinical and technical support to customers.
Read More »